Effect of hyperglycemia on stroke outcomes

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Claresa S Levetan

Abstract

To review published data about the relationship between hyperglycemia and the outcome of patients with stroke. Stroke is the most frequent cause of permanent disability in the Western world and the third leading cause of death among Americans. Each year, more than 500,000 Americans have a cerebrovascular accident. In the medical literature, numerous reports have discussed how hyperglycemia during acute stroke, regardless of a patient's prior diabetes status, has been associated with significantly higher morbidity, higher mortality, longer hospital stays, reduced long-term recovery, and diminished ability to return to work. In the United States alone, an estimated $300 million in additional health-care costs are incurred among hospitalized patients with stroke who also have high blood glucose levels. Treatment of hyperglycemia has safely, successfully, and effectively yielded glucose levels in the normal range in the hospital setting under the direction of specialty physicians and should be implemented in patients with stroke. Until convincing randomized prospective trials prove that tight glycemic control does not improve stroke outcomes, the overwhelming preponderance of data suggests that aggressive glucose management should ...Continue Reading

References

Oct 1, 1979·American Journal of Diseases of Children·D E Greydanus, A D Hofmann
Sep 15, 1992·Annals of Internal Medicine·D B MatcharJ R Feussner
Apr 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·L KiersS Ratnaike
Feb 1, 1992·Annals of Emergency Medicine·G M de Courten-MyersR E Myers
Jul 1, 1991·Stroke; a Journal of Cerebral Circulation·P A O'NeillD Bennett
Jun 1, 1991·Italian Journal of Neurological Sciences·G CazzatoL G Iona
Nov 1, 1991·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·C L Voll, R N Auer
Mar 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Jan 1, 1990·Behaviour Research and Therapy·V L GoetschB Van Dorsten
Oct 1, 1989·Postgraduate Medical Journal·C S GrayO F James
May 1, 1987·Diabetic Medicine : a Journal of the British Diabetic Association·C S GrayD Bates
Jul 1, 1988·American Journal of Epidemiology·E Barrett-Connor, K T Khaw
Mar 1, 1988·Journal of Pediatric Psychology·A M DelamaterJ V Santiago
May 1, 1988·Age and Ageing·M J PowerR W Stout
Apr 24, 1986·The New England Journal of Medicine·F W KemmerM Berger
Sep 1, 1986·Stroke; a Journal of Cerebral Circulation·L Berger, A M Hakim
Jun 1, 1985·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·B K SiesjöT Wieloch
Jul 1, 1985·Archives of Neurology·L CandeliseE Boccardi
Jun 1, 1981·The Journal of Pediatrics·H P Chase, G G Jackson
May 1, 1982·Stroke; a Journal of Cerebral Circulation·M C Riddle, J Hart
Jan 1, 1980·Acta Medica Scandinavica·K AsplundP O Wester
Feb 1, 1995·Journal of Neurosurgery·M G HamiltonR N Auer
Oct 1, 1994·Stroke; a Journal of Cerebral Circulation·H JørgensenT S Olsen
Aug 1, 1993·Stroke; a Journal of Cerebral Circulation·F van KootenP J Koudstaal
Jan 1, 1993·Stroke; a Journal of Cerebral Circulation·W D DietrichR Busto
Apr 1, 1993·Diabetes Care·M I Harris
Feb 1, 1997·Acta Neurologica Scandinavica·A CzłonkowskaW Lechowicz
Sep 1, 1997·The Journal of Clinical Investigation·H O SteinbergA D Baron
Apr 16, 1998·Diabetes Care·C S LevetanR E Ratner

❮ Previous
Next ❯

Citations

May 13, 2009·Current Treatment Options in Cardiovascular Medicine·Veronique Guyomard, Phyo Kyaw Myint
May 30, 2009·Neurocritical Care·Xi Liu-DeRykeDenise H Rhoney
Jun 12, 2010·International Journal of Stroke : Official Journal of the International Stroke Society·William J MeurerRobert Silbergleit
Jan 19, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·D FlanaganP Lynch
Feb 24, 2010·Journal of Clinical Pharmacy and Therapeutics·P M Szumita
Jan 2, 2015·The Neurohospitalist·Stephanie Rennke, Sumant R Ranji
Dec 24, 2005·Stroke; a Journal of Cerebral Circulation·Guy M McKhannOla A Selnes
Jan 31, 2007·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Franklin Michota, Susan S Braithwaite
Feb 8, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Lioubov S Boulkina, Susan S Braithwaite
Dec 20, 2013·Surgical Infections·Jonathan D'CunhaGregory J Beilman
Jun 17, 2018·Current Diabetes Reports·Estelle Everett, Nestoras Mathioudakis
May 24, 2016·The Journal of the American Osteopathic Association·Dustin JonesJay H Shubrook

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.